garenoxacin has been researched along with methadone in 1 studies
| Studies (garenoxacin) | Trials (garenoxacin) | Recent Studies (post-2010) (garenoxacin) | Studies (methadone) | Trials (methadone) | Recent Studies (post-2010) (methadone) |
|---|---|---|---|---|---|
| 195 | 19 | 46 | 13,630 | 1,463 | 3,957 |
| Protein | Taxonomy | garenoxacin (IC50) | methadone (IC50) |
|---|---|---|---|
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 7.5 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.0041 | |
| Delta-type opioid receptor | Homo sapiens (human) | 1.09 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.512 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 9.7724 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, CA; Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
1 other study(ies) available for garenoxacin and methadone
| Article | Year |
|---|---|
Extrapolation of preclinical pharmacokinetics and molecular feature analysis of "discovery-like" molecules to predict human pharmacokinetics.
Topics: Animals; Biometry; Dogs; Drug Evaluation, Preclinical; Haloperidol; Haplorhini; Humans; Injections, Intravenous; Liver; Liver Circulation; Metabolic Clearance Rate; Mifepristone; Molecular Structure; Molecular Weight; Rats; Reproducibility of Results | 2006 |